In his papers, Philip J. Rosenfeld integrates diverse fields, such as Ophthalmology and Optometry. Philip J. Rosenfeld merges Optometry with Ophthalmology in his study. He connects Macular degeneration with Retina in his research. His work blends Retina and Macular degeneration studies together. Choroidal neovascularization is closely attributed to Visual acuity in his work. He combines topics linked to Choroidal neovascularization with his work on Visual acuity. His research is interdisciplinary, bridging the disciplines of Serous fluid and Internal medicine. His Retrospective cohort study research extends to Surgery, which is thematically connected. His study in Internal medicine extends to Retrospective cohort study with its themes.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Ranibizumab for Neovascular Age-Related Macular Degeneration
Philip J. Rosenfeld;David M. Brown;Jeffrey S. Heier;David S. Boyer.
The New England Journal of Medicine (2006)
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies
Steven D. Schwartz;Carl D. Regillo;Byron L. Lam;Dean Eliott.
The Lancet (2015)
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Philip J Rosenfeld;Andrew A Moshfeghi;Carmen A Puliafito.
Ophthalmic Surgery Lasers & Imaging (2005)
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Anne E. Fung;Geeta A. Lalwani;Philip J. Rosenfeld;Sander R. Dubovy.
American Journal of Ophthalmology (2007)
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication
Katherine A. Jones;James T. Kadonaga;Philip J. Rosenfeld;Thomas J. Kelly.
Cell (1987)
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
Geeta A. Lalwani;Philip J. Rosenfeld;Anne E. Fung;Sander R. Dubovy.
American Journal of Ophthalmology (2009)
Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Week Results of an Uncontrolled Open-Label Clinical Study
Stephan Michels;Philip J. Rosenfeld;Carmen A. Puliafito;Erin N. Marcus.
Ophthalmology (2005)
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial
Emily Y. Chew;Traci E. Clemons;John Paul SanGiovanni;Ronald Danis.
JAMA (2013)
The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide
A.E. Fung;P.J. Rosenfeld;E. Reichel.
British Journal of Ophthalmology (2006)
Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein Occlusion
Philip J Rosenfeld;Anne E Fung;Carmen A Puliafito.
Ophthalmic Surgery Lasers & Imaging (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Miami
University of Southern California
University of Washington
University of Miami
University of California, Los Angeles
University of Miami
Tufts Medical Center
Johns Hopkins University School of Medicine
National Institutes of Health
Institute of Science and Technology Austria
University of Montreal
University of Chinese Academy of Sciences
Michigan State University
Macau University of Science and Technology
Johns Hopkins University
RMIT University
University of California, Davis
Washington State University
Leipzig University
University of Tokyo
University College London
Yokohama City University
University of Rhode Island
University of Western Australia
Johns Hopkins University Applied Physics Laboratory